Disease management
Also, fellow Korean medical AI companies have obtained regulatory approvals across global markets.
The company plans to offer an aggregate of 7.9 million shares of its common stock with an initial public offering price between $18 and $20 per share.
The model could be deployed as a decision support tool in emergency departments.
The funds will be used to help the company expand into the employer and health plan markets and speed up the development of its AI technology for providers and members.
The company began trading on the NYSE today under the ticker symbol HNGE, opening at $39.25, up 23% from its IPO price of $32, and closing at $37.56 per share.
MedStar Health and Abundant Venture Partners co-developed the model.
The AI-powered COPD care coordination tool uses EHR data and natural language processing to identify and manage high-risk patients.
The organization is seeking feedback on how to best advance digital health to empower seniors using technology, while reducing administrative burdens and improving interoperability.
The new service at Prince Philip Dental Hospital is said to be the first of its kind in the world.
Also, Bangkok Hospital has started installing smart mirrors for contactless vital signs measurement.